Acipimox
Product Sizes
100 mg
£ POA
HY-B0283-100MG
50 mg
£ POA
HY-B0283-50MG
About this Product
- SKU:
- HY-B0283
- Additional Names:
- K-9321
- CAS Number:
- 51037-30-0
- Extra Details:
- Acipimox (K-9321); a nicotinic acid analogue; is an antilipolytic compound. Acipimox stimulates leptin releas; inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity[1][2][3].
- Molecular Weight:
- 154.13
- Purity:
- 99.58
- References:
- [1]Vestergaard ET, et, al. Short-term acipimox treatment is associated with decreased cardiac parasympathetic modulation. Br J Clin Pharmacol. 2017 Dec;83(12):2671-2677.|[2]Wang-Fisher YL, et, al. Acipimox stimulates leptin production from isolated rat adipocytes. J Endocrinol. 2002 Aug;174(2):267-72.|[3]Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand. 2001 Feb;171(2):161-7.
- Research Area:
- Metabolic Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Metabolic Enzyme/Protease
